Identification of Metastatic Cell Nucleus in Human Prostate Cancer by Electron Microscopy

References

• SchirrmacherV. Cancer metastasis: experimental, approaches, theoretical concepts, and impacts for treatment strategies. Adv. Cancer Res.43, 1–73 (1985).
   PubMed Web of Science ®Google Scholar
• LiottaLA , Stetler-StevensonGW. Tumor invasion and metastasis: an imbalance of positive and negative regulation. Cancer Res.51, 5054–5059 (1991).
   PubMed Web of Science ®Google Scholar
• TarinD. Metastasis: secondary proliferation in distant organs. PusztaiL, LewisCE, YapE ( Eds). Oxford Univ Press, Oxford, UK, 317–341 (1996).
   Google Scholar
• SloaneBF , RozhinJ , JohnsonK , TaylorH , CrissmanJD , HonnKV. Cathepsin B: association with plasma membrane in metastatic tumors. Proc. Nat. Acad. Sci.83(8), 2483–2487 (1986).
   PubMed Web of Science ®Google Scholar
• Stetler-StevensonWG , YuAE. Proteases in invasion: matrix metalloproteinases. Semin. Cancer Biol.11(2), 143–152 (2001).
   PubMed Web of Science ®Google Scholar
• WilsonMJ , SinhaAA. Matrix degradation in prostate cancer. Chapter 11, 221–251. In: Metastasis of Prostate Cancer.AblinRJ, MasonMD ( Eds). Springer Science and Business, Dordrecht, The Netherlands, 21–251 (2007).
   Google Scholar
• KellyK , YinJJ. Prostate cancer and metastasis initiating stem cells. Cell Res.18, 528–537 (2008).
   PubMed Web of Science ®Google Scholar
• QuigleyDA , DangHA , ZhaiSG. Genomic hallmarks and structural variation in metastatic prostate cancer. Cell174, 1–12 (2018).
   PubMed Web of Science ®Google Scholar
• HanahanD , WeinbergRA. Hallmarks of cancer: the next generation. Cell144, 646–674 (2011).
   PubMed Web of Science ®Google Scholar
• RamelC. Relationship between mutagenesis and carcinogenesis. In: Mutation, Cancer, and Malformation.ChuE, GenerrosoWM ( Eds). Springer Nature Switzerland, Basel, Switzerland, 97–112 (1984).
   Google Scholar
• BrydenAA , FreemontAJ , ClarkeNW , GeorgeNJ. Ki-67 index in metastatic prostate cancer. Eur. Urol.40(6), 673–678 (2001).
   PubMed Web of Science ®Google Scholar
• LindboeCF , TorpSH. Comparison of Ki-67 equivalent antibodies. J. Clin. Pathol.55, 467–471 (2002).
   PubMed Web of Science ®Google Scholar
• WeissL. Metastatic inefficiency. Adv. Cancer Res.54, 150–211 (1981).
   Google Scholar
• SinhaA , BlackardCE , SealUS. A critical analysis of tumor morphology and hormone treatments in the untreated and estrogen-treated responsive and refractory human prostatic carcinoma. Cancer40(6), 2836–2850 (1977).
   PubMed Web of Science ®Google Scholar
• SinhaAA , WilsonMJ. Identification of two types of stem cells in methylene blue-stained sections of untreated and diethylstilbestrol -treated human prostate cancer and their characterization by immunogold localization of CD133. Anticancer Res.38, 5725–5732 (2018).
   PubMed Web of Science ®Google Scholar
• SinhaAA. Electron microscopic analysis of stem cell in human prostate cancer, including inverted capsule embedding methods for archival sections and falcon films for prostate cancer cell lines. Anticancer Res.39, 4171–4177 (2019).
   PubMedGoogle Scholar
• GleasonDF. Classification of prostatic carcinomas. Cancer Chemother. Rep.50, 125–128 (1966).
   PubMedGoogle Scholar
• GleasonDF. The veterans administration cooperative urologic research group. Histologic grading and clinical staging of prostatic carcinoma. In: Urologic Pathology: The Prostate.TannenbaumM ( Ed.). Lea & Febiger, PA, USA, 171–213 (1977).
   Google Scholar
• DiamondBA , BerrySJ , UmbrichtC , JewettHJ , CoffeyDS. Computerized image analysis of nuclear shape as a prognostic factor for prostate cancer. Prostate3(4), 321–332 (1981).
   Web of Science ®Google Scholar
• PartinAW , WalshAC , PitcockRV , MohlerJL , EpsteinJI , CoffeyDS. A comparison of nuclear morphometry and Gleason grade as a predictor of prognosis in stage A2 prostate cancer. A critical analysis. J. Urol.14(5), 1254–1258 (1989).
   Google Scholar
• WyattAW , AnnalaM , AggarwalRet al.Concordance of circulating tumor DNA and matched metastatic tissue biopsy in prostate cancer. J. Natl. Cancer Inst109(12), 2017).
   PubMedGoogle Scholar
• WeidleUH , EppA , BirzeleF , BrinkmannE. The functional role of prostate cancer metastasis-related mircoRNAs. Cancer Genomic Proteomics16(1), 1–19 (2019).
   PubMed Web of Science ®Google Scholar
• SinhaAA , BlackardCE. Ultrastructure of prostatic benign hyperplasia and carcinoma. Urology2, 114–120 (1973).
   PubMedGoogle Scholar
• SinhaAA , WilsonMJ , GleasonDJ. Immunoelectron microscopic localization of prostatic-specific antigen in human prostate by the protein A-gold complex. Cancer60(6), 1288–1293 (1987).
   PubMed Web of Science ®Google Scholar
• ReynoldsES. The use of lead citrate at high pH as an electron-opaque stain in electron microscopy. J. Cell Biol.1, 208–212 (1961).
   Google Scholar
• EllisWJ , LangePH. Prostate cancer. Endocrinol. Metab. Clin. North Am.23(4), 809–824 (1994).
   PubMed Web of Science ®Google Scholar
• DittmerTA , MisteliT. The lamin protein family. Genome Biol.12, 222 (2011).
   PubMed Web of Science ®Google Scholar
• SaarinenI , MirittiT , SeikkulaH , BostromPJ , TaimenP. Differential predictive roles of A and B-type nuclear lamins in prostate cancer progression. PLoS ONE10, 1–17 (2015).
   Web of Science ®Google Scholar
• SinhaAA , PomroyFE , WilsonMJ. Concurrent androgen and estrogen ablation and inhibition of steroid biosynthetic enzyme treatment for castration-resistant prostate cancer. Anticancer Res.36(8), 3847–3854 (2016).
   PubMed Web of Science ®Google Scholar
• RitchE , WyattAW. Predicting therapy response and resistance in metastatic prostate cancer with circulating tumor DNA. Urol. Oncol.36(8), 380–384 (2018).
   PubMed Web of Science ®Google Scholar
• RaskaI , OchsRL , Salamin-MichelL. Immunocytochemistry of the cell nucleus. Electron. Microsc. Rev.3, 301–353 (1990).
   PubMedGoogle Scholar
• ProkocimerM , DavidovichM , Nissim-RafiniaMet al.Nuclear lamins: key regulators of nuclear structure and activities. J. Cellular Molecular Med.13(6), 1059–1086 (2009).
   PubMed Web of Science ®Google Scholar
• PajerowskiJD , CahlKN , ZhongFL , SammakPJ , DischerDE. Physical plasticity of the nucleus in stem cell differentiation. Proc. Natl Acad. Sci. USA104(40), 15619–15624 (2017).
   Google Scholar
• CrawfordDE , SchellhammerPF , McLeodDGet al.Androgen receptor targeted treatments of prostate cancer: 35 years of progress with antiandrogens. J. Urol.200(5), 950–966 (2018).
   PubMed Web of Science ®Google Scholar
• Van EttenJL , DehmSM. Clonal origin and spread of metastatic prostate cancer. Endocrine Relat. Cancer23, R207–R217 (2016).
   PubMed Web of Science ®Google Scholar
• SinhaAA , BlackardCE , DoeRP , SealUS. The in vitro localization of H3 estradiol in human prostatic carcinoma: an electron microscopic autoradiographic study. Cancer31(3), 682–688 (1973).
   PubMed Web of Science ®Google Scholar
• BashirelahiN , YoungJD , ShidaKet al.Androgen, estrogen and progesterone receptors in peripheral and central zones of the human prostate with adenocarcinoma. Urol.21(5), 530–535 (1983).
   PubMed Web of Science ®Google Scholar
• GreeneGL , SobelNB , KingWJ , JensenEV. Immunohistochemical studies of estrogen receptors. J. Steroid Biochem.20(1), 1–56 (1984).
   Google Scholar
• HuWY , ShiGB , NellesJL , PrinsGS. Actions of estrogen and endocrine disrupting chemicals on human prostates stem/progenitor cells and prostate cancer risk. Mol. Cell Endocrinol.354, 63–73 (2012).
   PubMed Web of Science ®Google Scholar
• PagetS. Distribution of secondary growths in cancer of the breast. Lancet8(2), 98–101 (1889).
   Google Scholar